Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jaguar Health (JAGX) Other Accumulated Expenses (2016 - 2024)

Historic Other Accumulated Expenses for Jaguar Health (JAGX) over the last 10 years, with Q4 2024 value amounting to $661000.0.

  • Jaguar Health's Other Accumulated Expenses fell 6722.86% to $661000.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $661000.0, marking a year-over-year decrease of 6722.86%. This contributed to the annual value of $661000.0 for FY2024, which is 6722.86% down from last year.
  • Latest data reveals that Jaguar Health reported Other Accumulated Expenses of $661000.0 as of Q4 2024, which was down 6722.86% from $2.0 million recorded in Q4 2023.
  • In the past 5 years, Jaguar Health's Other Accumulated Expenses registered a high of $2.0 million during Q4 2023, and its lowest value of $661000.0 during Q4 2024.
  • Its 5-year average for Other Accumulated Expenses is $1.4 million, with a median of $1.5 million in 2022.
  • Per our database at Business Quant, Jaguar Health's Other Accumulated Expenses soared by 7423.31% in 2021 and then tumbled by 6722.86% in 2024.
  • Jaguar Health's Other Accumulated Expenses (Quarter) stood at $978000.0 in 2020, then surged by 74.23% to $1.7 million in 2021, then decreased by 13.03% to $1.5 million in 2022, then surged by 36.1% to $2.0 million in 2023, then tumbled by 67.23% to $661000.0 in 2024.
  • Its last three reported values are $661000.0 in Q4 2024, $2.0 million for Q4 2023, and $1.5 million during Q4 2022.